Variation of selected genotoxic and epigenetic markers due to therapeutic exposure to PAHs and ultraviolet radiation

Bratisl Lek Listy. 2020;121(8):558-564. doi: 10.4149/BLL_2020_093.

Abstract

Background: Goeckerman therapy (GT) of psoriasis involves dermal application of crude coal tar containing polycyclic aromatic hydrocarbons (PAHs) and exposure to ultraviolet radiation (UVR). Little is known about GT influence on DNA epigenetics.

Objective: The study aim was to discover epigenetic mechanisms altered by the exposure related to the GT of psoriasis.

Methods: Observed group of patients with plaque psoriasis (n = 23) was treated by GT with 3 % CCT. Before and after GT, we analyzed the levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts (BPDE-DNA), p53 protein in serum, 5-methylcytosine (5-mC, global DNA methylation), and methylation in selected CpG sites of p53 gene.

Results: We found a significant increase in the levels of BPDE-DNA (p < 0.01) and serum levels of p53 protein (p < 0.01) after GT, and an insignificant decrease in the percentage of 5-mC in peripheral blood DNA. Methylation of p53 CpG sites was affected neither by psoriasis nor by GT. The study confirmed good effectiveness of GT (significantly reduced psoriasis area and severity index; p < 0.001).

Conclusion: Our findings indicate that there is a significantly increased genotoxic hazard related to the exposure of PAHs and UV radiation after GT of psoriasis. However, global DNA methylation and p53 gene methylation evade the effect of GT, as they remained unchanged (Tab. 4, Fig. 3, Ref. 50).

Keywords: Goeckerman therapy; methylation; polycyclic aromatic hydrocarbons UV radiation.; psoriasis.

MeSH terms

  • DNA Damage
  • Epigenesis, Genetic* / drug effects
  • Humans
  • Polycyclic Aromatic Hydrocarbons* / adverse effects
  • Polycyclic Aromatic Hydrocarbons* / therapeutic use
  • Psoriasis* / therapy
  • Ultraviolet Rays
  • Ultraviolet Therapy* / adverse effects

Substances

  • Polycyclic Aromatic Hydrocarbons